The invention provides a new method for the treatment of anoxia of brain cells using a PGI.sub.1 derivative of the formula: ##STR1## wherein R.sub.1 represents hydrogen or lower alkyl and R.sub.2 represents 2-methylhexyl, 3-propylcyclopentyl, 3-butylcyclopentyl or 4-propylcyclohexyl, a PGI.sub.2 derivative of the formula: ##STR2## wherein R.sub.3 represents hydrogen or lower alkyl and R.sub.4 represents 2-methylhexyl, cyclopentyl, 3-propylcyclopentyl, or cyclohexyl, a PGI.sub.2 derivative of the formula: ##STR3## wherein R.sub.5 represents lower alkyl and R.sub.6 represents pentyl, 1-methylpentyl, 1-methyl-5-chloropentyl, 2-methyl-5-chloropentyl, 3-ethylcyclopentyl, 3-propylcyclopentyl, 3-butylcyclopentyl, 3-(2-chloroethyl)cyclopentyl, cyclohexyl, 4-ethylcyclohexy, or cyclohexylmethyl or a PGE.sub.1 derivative of the formula: ##STR4## wherein X represents methylene or carbonyl and (i) when X represents methylene, Y represents ethylene or trans-vinylene, R.sub.7 represents carboxy or lower alkoxycarbonyl and R.sub.8 represents 2-methylhexyl or 1-cyclohexylethyl and (ii) when X represents carbonyl, Y represents ethylene, R.sub.7 represents carboxyl, lower alkoxycarbonyl, glycoloyl or hydroxymethyl and R.sub.8 represents 2-methylhexyl, cyclopentyl, 3-propylcyclopentyl, or 3-butylcyclopentyl or a cyclodextrin clathrate or non-toxic salt thereof.

Ono Pharmaceutical Co., Ltd.

Method of anoxia treatment using prostaglandin analogues

The invention relates to a new method for the treatment of anoxia of brain cells using a PGI.sub.1 derivative of the formula: ##STR1## (wherein R represents an alkyl group of 1 to 4 carbon atoms.) or cyclodextrin clathrates thereof, or non-toxic salts thereof.

New method of treatment using prostaglandin analogues

A method of treating or preventing adhesion formation during or following a surgical procedure comprising administering to a patient in need thereof at least one medicament selected from the group consisting of potassium channels; modulators of macrophage activation and leucocyte attraction through cytokines, or their inhibitors, antibodies or inhibitors blocking the effect of VEGF expression; prostaglandin E1; free radical scavengers, lipid peroxysomes; pregnatrienes; calcium antagonists; hypoxia; acidosis; MP; dopamine; and ATP-MgCl.sub.2, wherein the method prevents adhesion formation by preventing anoxemia.

prostaglandin/hypoxia

Method of anoxia treatment using prostaglandin analogues

New method of treatment using prostaglandin analogues

Adhesion prevention and an endoscopic insufflation system therefor

La base de dades d’herbes medicinals més completa avalada per la ciència